Pulsenmore Ltd. income statement PLSM

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Pulsenmore Ltd. reported revenue of $12.5 million. It recorded a net loss of $5.0 million. Diluted earnings per share were $0.77.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

FY 2025
Dec 31, 2025
Revenue
13
Cost of revenue
2
Gross profit
11
Research and development
5
Selling, general and administrative
5
Pretax income
-5
Net income
-5
Basic EPS
0.77
Diluted EPS
0.77
Weighted average shares, basic
6
Other measures
Depreciation and amortization
1
Margins
Gross margin
84.16%
Pretax margin
-39.61%
Profit margin
-39.61%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
PLSM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Israel
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2064764

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.